According to the latest disclosure filing, Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) reported a change in shareholder equity on August 18, 2026.

The filing details that Wang Haibo, holding a long position, reduced his stake from 38,746,500 shares to 30,997,200 shares. This adjustment brings his current shareholding ratio to 4.36%, down from the previous 5.45%.

It is important to note that fluctuations in share counts may result from corporate actions such as rights issues, share consolidations, or stock splits. Investors are advised to verify these changes against the actual corporate events to ensure accurate interpretation.